COMP <GO>
SCL vs IPAR // PIOTROSKI F-SCORE QUALITY
Stepan Company (NYSE) VS. Interparfums Inc. (NASDAQ) • 15-METRIC TALLY: SCL 2
— IPAR 9
▲ PIOTROSKI F-SCORE QUALITY LEADER: IPAR
LAST: $69.61 (-0.54%) • MKT CAP: $1.59B
piotroski-score
7/9
LAST: $116.37 (+0.75%) • MKT CAP: $3.70B
piotroski-score
8/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SCL VS. IPAR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SCL | IPAR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 11.60% | 63.60% | -52.00 | IPAR | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 4.30% | 21.30% | -17.00 | IPAR | /roic <GO> |
| EV/EBITDA & P/E Valuation | 9.8x | 13.1x | -3.30 | SCL | /valuation <GO> |
| Free Cash Flow Yield | 1.59% | 5.15% | -3.56 | IPAR | /fcf-yield <GO> |
| Operating Margin | 3.40% | 18.20% | -14.80 | IPAR | /operating-margins <GO> |
| Net Profit Margin | 2.00% | 14.00% | -12.00 | IPAR | /net-margins <GO> |
| Revenue Growth (YoY) | 7.00% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.20% | 2.78% | -0.58 | IPAR | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 7.36 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 7/9 | 8/9 | -1.00 | IPAR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 77.1 | 52.5 | +24.60 | SCL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 31.5x | 16.6x | +14.90 | IPAR | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.59B | $3.70B | -$2.11B | IPAR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SCL REV | IPAR REV | SCL GROSS % | IPAR GROSS % | SCL FCF | IPAR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.33B | $1.49B | 11.6% | 63.6% | $25.4M | $190.5M |
| FY 2024 | $2.18B | $1.45B | 12.5% | 63.9% | $39.3M | $182.9M |
| FY 2023 | $2.33B | $1.32B | — | — | $174.9M | $105.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SCL // BETA —
IPAR // BETA —